- Published at
- by themarketherald.com.au
mixed
mixed
ASX Market Close: Tariff pause bounceback lifts animal spirits, but certainty elusive
Good Afternoon and welcome to HotCopper’s Market Close for Thursday 10th of April,…
News for Opthea Limited (OPT.AX)
- Published at
- by themarketherald.com.au
mixedmixedThursday’s HotCopper Trends: Sayona merger, Opthea slashes jobs | April 10, 2025
The ASX has been up, charging 4.7% higher at around 7,720 points…- Published at
- by themarketherald.com.au
negativenegativeOpthea, with shares still suspended, cuts workforce by 65% after drug trials cancelled
Troubled biotech stock Opthea (ASX:OPT), still in the process of crisis talks with investors, has flagged a workforce reduction of -65%.- Published at
- by raskmedia.com.au
positivepositiveOpthea (ASX:OPT) shares a business update with investors
Investors following Opthea Ltd (ASX:OPT) shares will want to know about the latest update from the business.- Published at
- by themarketherald.com.au
mixedmixedWednesday’s HotCopper Trends: MinRes down on iron ore slump, Regal Partners’ $540M funds loss | April 9, 2025
The Aussie bourse has continued its downward trend after Donald Trump promised sky high tariffs against China- Published at
- by manilatimes.net
positivepositiveOpthea Announces Decision to Discontinue Wet AMD Trials
**media[580863]**- Published at
- by themarketherald.com.au
positivepositiveWeek 13 Wrap: ASX nearly recovers 8000pts, then doesn’t – thanks Trump!
Welcome to the end of another week! The ASX nearly got back to 8,000pts where it climbed above in mid-Feb – notching fresh all-time-highs – before Trump tariff talks scared world markets the world over.- Published at
- by themarketherald.com.au
mixedmixedHotCopper Highlights for Week 13 – Opthea, Reject Shop, Bellevue & more!
Good Afternoon and welcome to HotCopper Highlights, I’m Jonathon Davidson. This is where we highlight what you were watching and discussing most on the forums this week. Let’s get into it.- Published at
- by gurufocus.com
mixedmixedOpthea Announces COAST Phase 3 Trial Topline Results
COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from baseline to week 52 Opthea considering impact of negative trial results und- Published at
- by manilatimes.net
mixedmixed- Published at
- by themarketherald.com.au
mixedmixedOpthea’s Phase 3 trial results fail to help patients, future of company at risk
It mightn't be too surprising that Opthea applied for a voluntary suspension last week ahead of Monday's Phase 3 trial results.- Published at
- by themarketherald.com.au
mixedmixedMonday’s HotCopper Trends: Opthea strife, Errawarra jumps on acquisitions, Memphasys best-in-class trial results | March 21, 2025
The ASX has been trading flat at around 7,928 points. Discretionary has…- Published at
- by themarketherald.com.au
positivepositiveWednesday’s HotCopper Trends: Imugene scores FDA tick, Arizona kicks off share purchase plan | March 19, 2025
The ASX has been trading flat at around 7,864 points. Financials has…- Published at
- by themarketherald.com.au
negativenegativeASX Market Open: Bounceback to survive a second day Down Under | March 18, 2025
Week 12’s global rally is holding firm early this Tuesday morning, with…- Published at
- by themarketherald.com.au
positivepositiveMonday’s HotCopper Trends: Spartan and Ramelius merger, Arizona capital raise | March 17, 2025
The ASX has been up 0.62% at 7,837 points, following Wall Street’s…- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Energy recovers Week 10 losses
Good afternoon and welcome to HotCopper’s Market Close, I’m Jonathon Davidson. The…- Published at
- by themarketherald.com.au
positivepositiveASX Market Close: Down below 8,100 we go as Brent Crude at 4Y low
Good Afternoon and welcome to HotCopper’s Market Close, I’m Jonathon Davidson.The ASX200 receded further just below the 8,100pts mark as the XJO continues to digest ongoing tariff implications.- Published at
- by gurufocus.com
positivepositiveOpthea Announces Phase 2b Wet AMD Publication
Baseline angiographic lesion characteristics predictive of clinical response Published in peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging Reti- Published at
- by gurufocus.com
positivepositiveOpthea Reports Half Year Results and Business Updates
Cash and cash equivalents of $131.9M as of December 31, 2024 Cash runway extends through anticipated topline data readouts of COAST (early 2Q CY25) and ShORe (- Published at
- by gurufocus.com
positivepositiveOpthea Completes Drug Product PPQ Campaign
Three consecutive commercial-scale drug product batches successfully produced Supports potential sozinibercept BLA filing in 1H CY2026 MELBOURNE, Australia